Skip to content
MediWatch Get free alerts

Mental Health Medication Shortage UK 2026

Is there a mental health medication shortage in the UK? Yes. 2 official notices cover mental health medicines: Venlafaxine 75mg immediate-release: shortage, expected until November 2026 (DHSC MSN/2026/040); Quetiapine 50/150/200/300/400mg MR: limited supply, no end date given (DHSC MSN/2025/006). Official data last checked .

Antidepressants, antipsychotics and mood stabilisers — full status tracker

Source data checked 12 November 2026, 06:18 UTC
2
Active official shortages
0
Active SSPs
Monitored
Historic rows

What changed in November 2026

  • November Venlafaxine 75mg immediate-release (DHSC MSN/2026/040): the notice gives this as the expected end of the shortage, unless it is updated.

From DHSC medicine supply notifications and NHSBSA Serious Shortage Protocols. Official data last checked 12 November 2026, 06:18 UTC. Every current UK shortage.

Need your medicine today?

Reduce repeat pharmacy checks

Track the exact medicine in this category

Mental health medicines can have different availability by brand, strength and formulation. Use the category page for context, then track the medicine page that matches your prescription.

If you have already run out, an emergency supply is usually faster than ringing round. Pharmacists cannot make an emergency supply of Schedule 1, 2 or 3 controlled drugs, such as ADHD stimulants, whoever asks (phenobarbital for epilepsy is the only exception): you need a new prescription, from your prescriber or through NHS 111. If you are still looking, check the national shortage status before you travel.

Get an emergency supply → Check stock & shortage status →
Mental health medication shortages hit differently. Unlike painkillers or blood pressure pills, stopping an antidepressant or antipsychotic abruptly can trigger severe withdrawal symptoms within hours. Venlafaxine 75mg immediate-release tablets are in shortage until November 2026 under a DHSC medicine supply notification issued on 26 August 2026 (MSN/2026/040). MediWatch's official data does not show an active fluoxetine shortage. This page keeps the historic context and safety advice, and each linked medicine page shows the live status from official data.

⚠️ Never Stop Mental Health Medication Abruptly

Suddenly stopping antidepressants or antipsychotics can cause dangerous discontinuation symptoms including severe anxiety, dizziness, nausea, electric shock sensations ("brain zaps"), insomnia and, rarely, seizures.

Current official data: DHSC's MSN/2026/040 (26 August 2026) says venlafaxine 75mg immediate-release tablets are out of stock until November 2026. MediWatch does not currently show an active fluoxetine shortage row. Quetiapine modified-release (XL) tablets — 50mg, 150mg, 200mg, 300mg and 400mg — remain under DHSC MSN/2025/006 (issued 10 February 2025, supply summary updated 13 August 2026); immediate-release quetiapine tablets remain available. Historic mental-health rows remain on this page for context, while the live tracker shows current DHSC, CPE and NHSBSA rows. See our data sources.

If your medication is unavailable: contact your pharmacy immediately. There is no Serious Shortage Protocol for any mental health medicine (NHSBSA, checked 17 October 2026), so any change of medicine, strength or form needs your prescriber. If nothing is available, see your GP the same day.

In crisis? Call the Samaritans on 116 123 (free, 24/7) or NHS 111.

Can You Suddenly Stop Venlafaxine or Quetiapine?

No — never stop venlafaxine or quetiapine abruptly, even if your pharmacy is temporarily out of stock. Both carry a well-documented discontinuation/withdrawal risk, and NHS guidance is explicit that any change in dose, brand or formulation should be managed by a prescriber, not decided by stock availability on the day.

Venlafaxine: why abrupt stopping is especially risky

Venlafaxine has one of the shortest half-lives of any commonly prescribed antidepressant, so missing even one or two doses can trigger discontinuation symptoms — dizziness, "brain zaps," nausea, anxiety and flu-like symptoms — within 24 hours. If your usual strength or brand is out of stock, ask your pharmacist first; there is no Serious Shortage Protocol for venlafaxine, so switching between immediate-release and modified-release needs your prescriber. If nothing is available, contact your GP or NHS 111 the same day rather than reducing your own dose. Check the live venlafaxine status page →

Quetiapine: why abrupt stopping is especially risky

Quetiapine, prescribed for schizophrenia, bipolar disorder and off-label for sleep or anxiety augmentation, can cause rebound insomnia, nausea and, at higher psychiatric doses, symptom relapse if stopped suddenly. Switching between immediate-release and modified-release (XL) quetiapine is not a simple swap — the release profile differs, so any change needs prescriber input rather than a same-strength pharmacy substitution. Check the live quetiapine status page →

Venlafaxine 75mg immediate-release tablets are under an active DHSC supply notification until November 2026 (MSN/2026/040, checked 2 October 2026); other venlafaxine strengths and forms remain available, though several cannot cover extra demand. Quetiapine modified-release (XL) tablets are under an active DHSC supply notification (MSN/2025/006, checked 2 October 2026); immediate-release tablets remain available and can support extra demand. The advice above applies regardless: never stop either medicine without talking to your pharmacist or GP first.

Quick Status: All Mental Health Drugs

Recent Supply Issues

💊 Antidepressants

Fluoxetine (Prozac)

Fluoxetine 10mg, 30mg & 40mg capsules/tablets

No current official shortageHistoric SSP

MediWatch's latest official data does not show active SSPs for fluoxetine. Historic SSPs affected 10mg, 30mg and 40mg presentations; the medicine page should be used for the live position.

Available: Fluoxetine 20mg capsules widely available (most common strength). Fluoxetine liquid 20mg/5ml available for flexible dosing. Your pharmacist can adjust capsule quantities to match your total daily dose.

Fluoxetine is the UK's most-prescribed SSRI, listed by NICE NG222 as a first-line antidepressant. There is no current fluoxetine shortage notice in MediWatch's official data (checked 15 October 2026). Historic fluoxetine SSPs under the DHSC SSP framework ran between 2019 and 2023 and have all expired.

Venlafaxine

Venlafaxine 75mg immediate-release tablets

Active shortage: Tier 2DHSC MSN/2026/040

Out of stock until November 2026. DHSC issued this medicine supply notification on 26 August 2026. The 2025 shortage of 37.5mg modified-release tablets (SSP083, MSN/2025/035) is historic: the August 2026 notice lists those tablets as available.

Available, per the MSN: venlafaxine 150mg MR capsules can support increased demand; 37.5mg and 75mg MR capsules and 75mg MR tablets can support a partial uplift. 37.5mg IR tablets, other MR tablet and capsule strengths, and the oral solutions remain available but cannot support extra demand. Any switch between immediate-release and modified-release needs your prescriber.

Venlafaxine has a notably short half-life, meaning discontinuation symptoms can begin within hours of a missed dose. It is especially important not to miss doses or run out.

🧠 Antipsychotics

Quetiapine (Seroquel)

Quetiapine 50mg, 150mg, 200mg, 300mg & 400mg modified-release (XL) tablets

Active — Tier 2DHSC MSN/2025/006

DHSC's medicine supply notification MSN/2025/006 (issued 10 February 2025) reports supply constraints on quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tablets. Community Pharmacy England updated the supply summary on 13 August 2026; the latest resupply detail sits on the SPS Medicines Supply Tool. Checked 2 October 2026. The older 2024 SSPs for 150mg, 200mg and 300mg immediate-release tablets have expired.

Available (per the MSN): quetiapine immediate-release tablets remain available and can support increased demand. Unlicensed imported XL tablets can be sourced by specialist importers where IR is not suitable — your prescriber decides.

Switching between IR and MR (XL) quetiapine is not straightforward — any switch must be managed by your prescriber. The total daily dose may need adjusting.

Drugs NOT Currently in Shortage

Good news: Sertraline, citalopram, escitalopram, mirtazapine and lithium have no active DHSC notice or Serious Shortage Protocol in MediWatch's official data (checked 15 October 2026).

Understanding Mental Health Drug Classes

What to Do If Your Mental Health Medication Is Affected

Support in Crisis

Further Reading

Related Condition Pages

Track your mental health medications

Check fluoxetine shortages free

Sign up free — takes 30 seconds →
Data sources: DHSC Medicine Supply Notifications · NHSBSA Serious Shortage Protocols · Mind · Royal College of Psychiatrists
Source data checked: 12 November 2026, 06:18 UTC.
MW
MediWatch
Checked against official UK sources

This content was researched and written by the MediWatch UK team using official government data sources. All shortage information is sourced directly from DHSC Medicine Supply Notifications and NHSBSA Serious Shortage Protocols. See our editorial policy and data sources for full methodology.